
Zimbabwe's hospitality sector is experiencing a significant funding shortfall of up to US$30 million in anticipation of the IATF 2029 event. This financial challenge is highlighted amidst various other news items, including a decline in export and paper division volumes for a manufacturer in its third quarter to June 2022 financial update, power outages and raw material shortages affecting ART operations, and rising confidence in ZMX with trades reaching US$1.28 million. Other reports cover political tensions leading to violence, the commissioning of a specialized honey testing laboratory to boost export competitiveness, and a Chinese mining firm donating a mini-bus to Shurugwi FC.
Free daily or weekly digest of the most important stories from across 18 African countries. No spam, unsubscribe any time.
This summary was AI-generated from a story originally published by NewsDay Zimbabwe.
Must ReadZimbabwe has commissioned a specialized honey testing laboratory. This initiative aims to enhance the country's export competitiveness in the honey market. The development is expected to support local producers and ensure the quality of Zimbabwean honey for international trade.

Zimbabwe has commissioned a specialized honey testing laboratory. This initiative aims to enhance the country's export competitiveness in the honey sector.

Zimbabwe's government has deployed health workers and established temporary clinics at ports of entry to provide returning citizens from South Africa with up to five days of antiretroviral ART medication. Health and Child Care Minister Douglas Mombeshora informed the National Assembly that over 99,000 returnees have been screened at the country's borders. Health checks are also being conducted for travelers transiting through Zimbabwe to Malawi and Zambia. Mombeshora stated that returnees are screened for chronic illnesses, including HIV, diabetes, and hypertension, at all entry points. Emergency ART clinics at border posts dispense a maximum five-day supply of medication, allowing patients to travel to their home districts where they are required to register for long-term treatment after baseline tests. The minister explained that Zimbabwe cannot immediately place returnees on long-term treatment at the border due to differing HIV treatment regimens between Zimbabwe and South Africa. He also noted that the government does not currently use technology or pre-trained models to match South African and Zimbabwean treatment protocols. Additionally, Mombeshora mentioned that the government is coordinating with regional partners to enhance disease surveillance and prevent communicable diseases from crossing Zimbabwe's borders.